Passage Bio Inc.
Passage Bio Inc. (PASG) — Form 8-K: Current report
About this filing
Passage Bio Inc. (PASG) filed an 8-K on Nov 6, 2026 reporting an executive or director change or pay arrangement (Item 5.02) and shareholder vote results (Item 5.07), with exhibits (Item 9.01).
Key facts
- Item 5.02 · Executive or director change or pay arrangement
- Item 5.07 · Shareholder vote results
- Item 9.01 · Financial statements and exhibits
More PASG filings
- 8-K
Filed Nov 19, 2026
- 8-K
Filed Nov 19, 2026
- 8-K
Filed Nov 18, 2026
- 10-Q
Filed Nov 10, 2026
- EFFECT
Filed Oct 12, 2026
- 424B3
Filed Oct 9, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.